Neurogene Inc. | SEC Filings

Filing Date	Form	Description	Filing Group	View
Mar 06, 2014	EFFECT	EFFECT	Other	View HTML 9999999995-14-000604.pdf 9999999995-14-000604.rtf 9999999995-14-000604.xls
Mar 06, 2014	CT ORDER	CT ORDER	Other	View HTML 9999999997-14-001443.pdf
Mar 04, 2014	CERTNAS	CERTNAS	Other	View HTML 9999999997-14-001330.pdf 9999999997-14-001330.rtf
Mar 04, 2014	CORRESP	CORRESP	Other	View HTML 0001193125-14-082143.pdf 0001193125-14-082143.rtf 0001193125-14-082143.xls
Mar 04, 2014	CORRESP	CORRESP	Other	View HTML 0001193125-14-082150.pdf 0001193125-14-082150.rtf 0001193125-14-082150.xls
Jan 28, 2014	CORRESP	CORRESP	Other	View HTML 0001193125-14-024964.pdf 0001193125-14-024964.rtf 0001193125-14-024964.xls
Jan 09, 2014	UPLOAD	UPLOAD	Other	View HTML 0000000000-14-001094.pdf
Dec 24, 2013	DRSLTR	Correspondence Related to Draft Registration Statement		View HTML 0000950123-13-010601.pdf 0000950123-13-010601.rtf
Dec 24, 2013	DRS/A	Amendment to a previously filed DRS	Registration Statements	View HTML 0000950123-13-010600.pdf 0000950123-13-010600.rtf 0000950123-13-010600.xls
Dec 19, 2013	UPLOAD	UPLOAD	Other	View HTML 0000000000-13-068920.pdf

Data provided by Kaleidoscope.

Form 8937

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 in order to report organizational actions, including nontaxable distributions that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only. Please consult your personal tax advisor for assistance as to how this information will impact your specific tax situation.